Polyethylene glycol diisocyanate decreases platelet deposition after balloon injury of rabbit femoral arteries

Journal of Thrombosis and Thrombolysis

Volumn 13, Issue 1, 2002, Pages 27-33

  Burchenal, J E B ^a   Deible, C R ^b   Deglau, T E ^b   Russell, A J ^b   Beckman, E J ^b   Wagner, W R ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Angioplasty; Platelet deposition inhibitor; Poly(ethylene glycol); Thrombosis

Indexed keywords

ANTITHROMBOCYTIC AGENT; CELL ADHESION MOLECULE; INDIUM 111; MACROGOL DIISOCYANATE; THROMBOCYTE RECEPTOR; UNCLASSIFIED DRUG; ISOCYANIC ACID DERIVATIVE; MACROGOL DERIVATIVE; POLYETHYLENE GLYCOL DIISOCYANATE; POLYETHYLENE GLYCOL-DIISOCYANATE;

ANGIOPLASTY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA BALLOON; ARTERIOTOMY; ARTERY INJURY; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL WALL; COMPARATIVE STUDY; CONTROLLED STUDY; COULTER COUNTER; DRUG SCREENING; FEMORAL ARTERY; FEMORAL ARTERY FLOW; FOGARTY CATHETER; GAMMA RADIATION; HYPERPLASIA; IN VIVO STUDY; INFUSION; ISOLATED ARTERY; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RABBIT; RADIOACTIVITY; RESTENOSIS; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE COUNT; THROMBOSIS; ANIMAL; DRUG EFFECT; INJURY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; THROMBOCYTE ADHESIVENESS; THROMBOCYTE AGGREGATION;

ANGIOPLASTY, BALLOON; ANIMAL; FEMORAL ARTERY; ISOCYANATES; PLATELET ADHESIVENESS; PLATELET AGGREGATION; POLYETHYLENE GLYCOLS; RABBITS; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS;

EID: 0035985001     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015364024487     Document Type: Article

References (19)

1. Abrupt vessel closure
2. Restenosis: The clinical issues
3. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease
4. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
5. Platelet accumulation in experimental angioplasty: Time course and relation to vascular injury
6. Role of platelets in restenosis after percutaneous coronary revascularization
7. Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty
8. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty
9. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
10. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: Results at six months
11. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
12. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein - IIb/IIIa blockade
13. Introduction to biotechnical and biomedical applications of poly(ethylene glycol)
14. Creating molecular barriers to acute platelet deposition on damaged arteries with reactive polyethylene glycol
15. Molecular barriers to biomaterial thrombosis by modification of surface proteins with polyethylene glycol
16. Initial platelet deposition at the human microvascular anastomosis: Effect on downstream platelet deposition to intact and injured vessels
17. Inhibition of thrombosis and intimal thickening by in situ photopolymerization of thin hydrogel barriers
18. Separation of the arterial wall from blood contact using hydrogel barriers reduces intimal thickening after balloon injury in the rat: The roles of medial and luminal factors in arterial healing
19. Renal handling of β2-microglobin in experimental renal disease